Perbedaan MNC Land Tbk. dan Organon Pharma Indonesia Tbk.: MNC Land Tbk. diperdagangkan di Rp79 (kapitalisasi pasar 9,12 T, volume 24 jam 2,15 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: MNC Land Tbk. jauh lebih besar — sekitar 87,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KPIG | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 9,12 T | 104,4 M |
Volume | 2,15 M | — |
Lot | 21,49 jt | — |
Perputaran | 173,67 M | — |
Harga Rata-rata | 80,82 | — |
Nilai Transaksi | 173,67 M | — |
Harga Ekuilibrium Indikatif | 79 | — |
Volume Ekuilibrium Indikatif | 116,99 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT MNC Land Tbk, formerly PT Global Land Development Tbk ( PT Kridaperdana Indahgraha Tbk ) was established based on Notarial Deed No. 65 dated June 11, 1990 of Achmad Fatimah, S.H., a substitute notary of Imas Fatimah, S.H., notary in Jakarta as amended by deed No. 72 dated October 19, 1990 of Imas Fatimah, S.H., notary in Jakarta. Subsequently, the notarial deed was amended by deed No. 129 dated June 26, 1991 of Achmad Bajumi, S.H., substitute notary of Imas Fatimah, S.H., notary in Jakarta.
Selengkapnya di halaman KPIG →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →